This is truly outrageous ... am hoping CytoDyn's attorneys can find comparable public company CEOs who've said far more speculative/inflammatory commentary about their drugs under trials ... they, unlike CytoDyn, probably did not get this kind of reprimanding letter issued by the FDA.